相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Delphine Planas et al.
NATURE (2022)
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection
Ital Nemet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant
Aurelien Sokal et al.
IMMUNITY (2022)
COVID-19-neutralizing antibodies predict disease severity and survival
Wilfredo F. Garcia-Beltran et al.
CELL (2021)
The Role of Interleukin-6 in the Pathogenesis, Prognosis and Treatment of Severe COVID-19
Ilias Giannakodimos et al.
CURRENT MEDICINAL CHEMISTRY (2021)
Looking beyond COVID-19 vaccine phase 3 trials
Jerome H. Kim et al.
NATURE MEDICINE (2021)
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
I. O. Rosas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani et al.
LANCET (2021)
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Delphine Planas et al.
NATURE MEDICINE (2021)
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
David S. Khoury et al.
NATURE MEDICINE (2021)
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Delphine Planas et al.
NATURE (2021)
Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery
Chengqian Feng et al.
NATURE COMMUNICATIONS (2021)
Effectiveness of Tocilizumab in Patients Hospitalized With COVID-19 A Follow-up of the CORIMUNO-TOCI-1 Randomized Clinical Trial
Xavier Mariette et al.
JAMA INTERNAL MEDICINE (2021)
Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis
Mathilde Roumier et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2021)
Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated Rejection
Bong-Ha Shin et al.
TRANSPLANTATION (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial
Chao Zhang et al.
LANCET NEUROLOGY (2020)
A minimal common outcome measure set for COVID-19 clinical research
J. C. Marshall et al.
LANCET INFECTIOUS DISEASES (2020)
Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm
Chuang Guo et al.
NATURE COMMUNICATIONS (2020)
Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients
Renata Varnaite et al.
JOURNAL OF IMMUNOLOGY (2020)
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19
Matthew C. Woodruff et al.
NATURE IMMUNOLOGY (2020)
Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study
Mar Masia et al.
EBIOMEDICINE (2020)
B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients
Victor A. Sosa-Hernandez et al.
FRONTIERS IN IMMUNOLOGY (2020)
Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study
Ajinkya Pawar et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
The Role of Interleukin 6 During Viral Infections
Lauro Velazquez-Salinas et al.
FRONTIERS IN MICROBIOLOGY (2019)
CD27-IgD-memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis
Zafar Mahmood et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis
Meliha C. Kapetanovic et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Cytokine-meciated regulation of plasma cell generation: IL-21 takes center stage
Leen Moens et al.
FRONTIERS IN IMMUNOLOGY (2014)
Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis
Shunsuke Mori et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Sustained Remission of Multicentric Castleman Disease in Children Treated with Tocilizumab, an Anti-Interleukin-6 Receptor Antibody
Caroline Galeotti et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Impact of IL-6 receptor inhibition on human memory B cells in vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory B cells
Khalid Muhammad et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
In Vivo Effects of the Anti-Interleukin-6 Receptor Inhibitor Tocilizumab on the B Cell Compartment
Petra Roll et al.
ARTHRITIS AND RHEUMATISM (2011)
Tocilizumab in Systemic Lupus Erythematosus Data on Safety, Preliminary Efficacy, and Impact on Circulating Plasma Cells From an Open-Label Phase I Dosage-Escalation Study
Gabor G. Illei et al.
ARTHRITIS AND RHEUMATISM (2010)
IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production
Kenichiro Maeda et al.
BLOOD (2010)
Circulating Antibody-Secreting Cells during Acute Respiratory Syncytial Virus Infection in Adults
F. Eun-Hyung Lee et al.
JOURNAL OF INFECTIOUS DISEASES (2010)